Pharmacy Today, December 2012

December 2012 • Volume 18, Number 12


37   Focus on respiratory disease: Asthma trials evaluate key treatments, including LABAs, ICSs, and tiotropium

39   Omacetaxine: Accelerated approval granted to novel agent for refractory CML

42   Perampanel: New drug indicated for adjunctive therapy for partial-onset seizures

44   Ocriplasmin: First-ever agent for symptomatic vitreomacular adhesion

46   MTM profile: Giberson promotes expanded pharmacy practice, provider status

49   Fungal meningitis: FDA reports on inspections of NECC, Ameridose facilities

50   Compounding: Post for your patients; Frequently asked questions about pharmaceutical compounding

54   Project IMPACT: Public health in Alabama helps patients, educates students

Policy and Advocacy

58   On the docket: Pharmacist–expert's report ruled sufficient

59   Hub on policy and advocacy: ACA implementation; Congress to tackle compounding

62   DEA scrutiny: Drug distributors, wholesalers under the magnifying glass

64   Electronic health records: Pharmacists can contribute to meaningful use


3   Bulletin: HIV screening, diabetes prevalence, meditation and heart disease, exercise for Parkinson disease

4   Letter to the editor: Value of APhA membership

6   Today's perspective: Holiday wish: Better med use

12   Pharmacists in action: CEO editorial, 'Minute with' Susan Holden, JFPS 2012

23   Product showcase: New indications, formulations, generics; product withdrawal

24   OTCs today: OTC antihistamines in older patients

27   Integrative medicine: Zinc supplements in ADHD

28   Immunization update: Tdap in pregnancy; HPV vaccine

31   One to one: Counseling special populations

33   MTM pearls: Facilitating change in pharmacy practice

80   ISMP error alert: Incorporating health literacy concerns into design of medication labels

Health-System Edition

HSE 2   Insomnia: Meeting 2013 National Patient Safety Goals

HSE 4   Many faces of MTM: Poppe ensures tech competency to move practice forward at UNC Hospitals

HSE 8   Antimicrobial stewardship: AHRQ toolkit targets C. difficile infections